These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 34160091

  • 1. Socioeconomic Status and Survival in Nasopharyngeal Carcinoma: A Population-Based Study.
    Brody-Camp S, McCoul ED, Lefante JJ, Aslam R.
    Laryngoscope; 2021 Dec; 131(12):2719-2723. PubMed ID: 34160091
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients.
    Pan XX, Liu YJ, Yang W, Chen YF, Tang WB, Li CR.
    Laryngoscope; 2020 Mar; 130(3):E83-E88. PubMed ID: 31188486
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Validation of Stage N3 of the Eighth Edition AJCC Staging System for Nasopharyngeal Carcinoma.
    Pan XB, Qu S, Li L, Chen L, Liang SX, Zhu XD.
    Laryngoscope; 2021 Mar; 131(3):535-540. PubMed ID: 32557662
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study.
    Hong RL, Hsiao CF, Ting LL, Ko JY, Wang CW, Chang JTC, Lou PJ, Wang HM, Tsai MH, Lai SC, Liu TW.
    Ann Oncol; 2018 Sep 01; 29(9):1972-1979. PubMed ID: 30016391
    [Abstract] [Full Text] [Related]

  • 12. Maximal lymph nodal diameter on N stage of nasopharyngeal carcinoma.
    Huang ST, Qu S, Li L, Chen KH, Zhu XD, Pan XB.
    Medicine (Baltimore); 2021 Jul 02; 100(26):e26543. PubMed ID: 34190192
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Short-term OS as a surrogate endpoint for 5-year OS in nasopharyngeal carcinoma in non-endemic area.
    Guan Y, Han L, Luo HY, Yu BB, Huang ST.
    World J Surg Oncol; 2024 Jul 11; 22(1):180. PubMed ID: 38987785
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.